References
1. Emery AE. Population frequencies of inherited neuromuscular diseases–a world survey. Neuromuscular disorders : NMD . 1991;1:19-29.
2. Parsons EP, Bradley DM and Clarke AJ. Newborn screening for Duchenne muscular dystrophy. Archives of disease in childhood . 2003;88:91-2.
3. McKusick VA. Mendelian Inheritance in Man and its online version, OMIM. American journal of human genetics . 2007;80:588-604.
4. Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba GK, Ciafaloni E, Cunniff C, Druschel CM, Mathews KD, Matthews DJ, Meaney FJ, Andrews JG, Conway KM, Fox DJ, Street N, Adams MM, Bolen J and STARnet MD. Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics . 2015;135:513-21.
5. Fairclough RJ, Bareja A and Davies KE. Progress in therapy for Duchenne muscular dystrophy.Experimental physiology . 2011;96:1101-13.
6. Zhou L and Lu H. Targeting fibrosis in Duchenne muscular dystrophy. Journal of neuropathology and experimental neurology . 2010;69:771-6.
7. Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S, Kunkel LM, Hoffman EP and Rowland LP. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell . 1988;54:447-52.
8. Perloff JK, de Leon AC, Jr. and O’Doherty D. The cardiomyopathy of progressive muscular dystrophy.Circulation . 1966;33:625-48.
9. Wells DJ, Ferrer A and Wells KE. Immunological hurdles in the path to gene therapy for Duchenne muscular dystrophy. Expert reviews in molecular medicine . 2002;4:1-23.
10. Chamberlain JS. Gene therapy of muscular dystrophy. Human molecular genetics . 2002;11:2355-62.
11. Roberts M and Dickson G. The future of Duchenne muscular dystrophy gene therapy: shrinking the dystrophin gene. Current opinion in molecular therapeutics . 2002;4:343-8.
12. Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt JF, Brooks SV and Chamberlain JS. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.Nature medicine . 2002;8:253-61.
13. Matsuo M. Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy.IUBMB life . 2002;53:147-52.
14. Duan D. Dystrophin Gene Replacement and Gene Repair Therapy for Duchenne Muscular Dystrophy in 2016: An Interview. Human gene therapy Clinical development . 2016;27:9-18.
15. Duan D. Dystrophin gene replacement and gene repair therapy for Duchenne muscular dystrophy in 2016. Human gene therapy Clinical development . 2016.
16. de Kermadec JM, Becane HM, Chenard A, Tertrain F and Weiss Y. Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study. American heart journal . 1994;127:618-23.
17. Angermann C, Spes C and Pongratz D. [Cardiac manifestation of progressive muscular dystrophy of the Duchenne type]. Zeitschrift fur Kardiologie . 1986;75:542-51.
18. Manzur AY, Kinali M and Muntoni F. Update on the management of Duchenne muscular dystrophy.Archives of disease in childhood . 2008;93:986-90.
19. Nigro G, Comi LI, Politano L and Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol . 1990;26:271-7.
20. Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J and et al. Randomized, double-blind six-month trial of prednisone in Duchenne’s muscular dystrophy. The New England journal of medicine . 1989;320:1592-7.
21. Bushby K, Muntoni F, Urtizberea A, Hughes R and Griggs R. Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands. Neuromuscular disorders : NMD . 2004;14:526-34.
22. Merlini L, Gennari M, Malaspina E, Cecconi I, Armaroli A, Gnudi S, Talim B, Ferlini A, Cicognani A and Franzoni E. Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up. Muscle & nerve . 2012;45:796-802.
23. Markham LW, Spicer RL, Khoury PR, Wong BL, Mathews KD and Cripe LH. Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol . 2005;26:768-71.
24. Mehmood M, Hor KN, Al-Khalidi HR, Benson DW, Jefferies JL, Taylor MD, Egnaczyk GF, Raman SV, Basu SK, Cripe LH, Germann J and Mazur W. Comparison of right and left ventricular function and size in Duchenne muscular dystrophy. Eur J Radiol . 2015;84:1938-42.
25. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R and Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord . 2002;12:926-9.
26. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J and Constantin C. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol . 2010;9:77-93.
27. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J and Constantin C. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol . 2010;9:177-89.
28. Simonds AK, Muntoni F, Heather S and Fielding S. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax . 1998;53:949-52.
29. Kieny P, Chollet S, Delalande P, Le Fort M, Magot A, Pereon Y and Perrouin Verbe B. Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011. Ann Phys Rehabil Med . 2013;56:443-54.
30. Hor KN, Gottliebson WM, Carson C, Wash E, Cnota J, Fleck R, Wansapura J, Klimeczek P, Al-Khalidi HR, Chung ES, Benson DW and Mazur W. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis.JACC Cardiovasc Imaging . 2010;3:144-51.
31. Tran D, Kamani AA, Lessoway VA, Peterson C, Hor KW and Rohling RN. Preinsertion paramedian ultrasound guidance for epidural anesthesia. Anesth Analg . 2009;109:661-7.
32. Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson DW and Gottliebson WM. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.J Am Coll Cardiol . 2009;53:1204-10.
33. Hor KN, Taylor MD, Al-Khalidi HR, Cripe LH, Raman SV, Jefferies JL, O’Donnell R, Benson DW and Mazur W. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn R . 2013;15.
34. Soslow JH, Xu M, Slaughter JC, Stanley M, Crum K, Markham LW and Parra DA. Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging. J Am Soc Echocardiogr . 2016.
35. Buddhe S, Lewin M, Olson A, Ferguson M and Soriano BD. Comparison of left ventricular function assessment between echocardiography and MRI in Duchenne muscular dystrophy. Pediatric radiology . 2016;46:1399-408.
36. Mendell JR and Lloyd-Puryear M. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy. Muscle Nerve . 2013;48:21-6.
37. Hor KN, Taylor MD, Al-Khalidi HR, Cripe LH, Raman SV, Jefferies JL, O’Donnell R, Benson DW and Mazur W. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson . 2013;15:107.
38. Ryan TD, Taylor MD, Mazur W, Cripe LH, Pratt J, King EC, Lao K, Grenier MA, Jefferies JL, Benson DW and Hor KN. Abnormal circumferential strain is present in young Duchenne muscular dystrophy patients. Pediatr Cardiol . 2013;34:1159-65.
39. D’Amario D, Amodeo A, Adorisio R, Tiziano FD, Leone AM, Perri G, Bruno P, Massetti M, Ferlini A, Pane M, Niccoli G, Porto I, D’Angelo GA, Borovac JA, Mercuri E and Crea F. A current approach to heart failure in Duchenne muscular dystrophy.Heart . 2017;103:1770-1779.
40. Moriuchi T, Kagawa N, Mukoyama M and Hizawa K. Autopsy analyses of the muscular dystrophies. The Tokushima journal of experimental medicine . 1993;40:83-93.
41. Basset O, Boittin FX, Cognard C, Constantin B and Ruegg UT. Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes. The Biochemical journal . 2006;395:267-76.
42. Constantin B, Sebille S and Cognard C. New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD. Journal of muscle research and cell motility . 2006;27:375-86.
43. Schreiber A, Smith WL, Ionasescu V, Zellweger H, Franken EA, Dunn V and Ehrhardt J. Magnetic resonance imaging of children with Duchenne muscular dystrophy. Pediatric radiology . 1987;17:495-7.
44. Kim RJ, Chen EL, Lima JA and Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation . 1996;94:3318-26.
45. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ and Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation . 1999;100:1992-2002.
46. Kim RJ and Manning WJ. Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine? Circulation . 2004;109:2476-9.
47. Kim RJ, Shah DJ and Judd RM. How we perform delayed enhancement imaging. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance . 2003;5:505-14.
48. Hor KN, Kissoon N, Mazur W, Gupta R, Ittenbach RF, Al-Khalidi HR, Cripe LH, Raman SV, Puchalski MD, Gottliebson WM and Benson DW. Regional Circumferential Strain is a Biomarker for Disease Severity in Duchenne Muscular Dystrophy Heart Disease: A Cross-Sectional Study. Pediatr Cardiol . 2015;36:111-119.
49. Hor KN, Mazur W, Taylor MD, Al-Khalidi HR, Cripe LH, Jefferies JL, Raman SV, Chung ES, Kinnett KJ, Williams K, Gottliebson WM and Benson DW. Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance. J Cardiovasc Magn Reson . 2011;13:60.
50. Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E and Gottliebson WM. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? International Journal of Cardiovascular Imaging . 2009;25:57-63.
51. Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M and Rochitte CE. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy.Journal of the American College of Cardiology . 2007;49:1874-9.
52. Perloff JK, Henze E and Schelbert HR. Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging.Circulation . 1984;69:33-42.
53. Ashford MW, Jr., Liu W, Lin SJ, Abraszewski P, Caruthers SD, Connolly AM, Yu X and Wickline SA. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging.Circulation . 2005;112:2462-7.
54. Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson W and Gottliebson WM. Circumferential Strain Analysis Identifies Strata of Cardiomyopathy in Duchenne Muscular Dystrophy A Cardiac Magnetic Resonance Tagging Study. J Am Coll Cardiol . 2009;53:1204-1210.
55. Hagenbuch SC, Gottliebson WM, Wansapura J, Mazur W, Fleck R, Benson DW and Hor KN. Detection of Progressive Cardiac Dysfunction by Serial Evaluation of Circumferential Strain in Patients With Duchenne Muscular Dystrophy. Am J Cardiol . 2010;105:1451-1455.
56. Menon SC, Etheridge SP, Liesemer KN, Williams RV, Bardsley T, Heywood MC and Puchalski MD. Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy.Pediatr Cardiol . 2014;35:1279-85.
57. McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med . 2010;362:228-38.
58. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ and Wilkoff BL. 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation . 2013;128:E240-E327.
59. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the D, Treatment of A, Chronic Heart Failure of the European Society of C, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P and Guidelines ESCCfP. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail . 2012;14:803-69.
60. Nagai T and Anzai T. [NYHA functional classification and AHA/ACC Stages for heart failure management]. Nihon Rinsho . 2016;74 Suppl 6:340-4.
61. Scrutinio D, Lagioia R, Ricci A, Clemente M, Boni L and Rizzon P. Prediction of Mortality in Mild to Moderately Symptomatic Patients with Left-Ventricular Dysfunction - the Role of the New-York-Heart-Association Classification, Cardiopulmonary Exercise Testing, 2-Dimensional Echocardiography and Holter Monitoring.European Heart Journal . 1994;15:1089-1095.
62. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Creager MA, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Stevenson WG and Yancy CW. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation . 2013;128:1810-1852.
63. Rorth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, Kober L, Prescott MF, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M and McMurray JJV. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Circ-Heart Fail . 2020;13.
64. Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR and Olson AK. Cardiac Management of the Patient With Duchenne Muscular Dystrophy.Pediatrics . 2018;142:S72-S81.
65. Hor KN, Mah ML, Johnston P, Cripe TP and Cripe LH. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord . 2018;28:711-716.
66. Feingold B, Mahle WT, Auerbach S, Clemens P, Domenighetti AA, Jefferies JL, Judge DP, Lal AK, Markham LW, Parks WJ, Tsuda T, Wang PJ, Yoo SJ, American Heart Association Pediatric Heart Failure Committee of the Council on Cardiovascular Disease in the Y, Council on Clinical C, Council on Cardiovascular R, Intervention, Council on Functional G, Translational B and Stroke C. Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association. Circulation . 2017;136:e200-e231.
67. Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM and Group DMDCCW. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.Lancet Neurol . 2018;17:347-361.
68. Connuck DM, Sleeper LA, Colan SD, Cox GF, Towbin JA, Lowe AM, Wilkinson JD, Orav EJ, Cuniberti L, Salbert BA, Lipshultz SE and Pediatric Cardiomyopathy Registry Study G. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J . 2008;155:998-1005.
69. Giglio V, Pasceri V, Messano L, Mangiola F, Pasquini L, Dello Russo A, Damiani A, Mirabella M, Galluzzi G, Tonali P and Ricci E. Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy. J Am Coll Cardiol . 2003;42:309-16.
70. Sasaki K, Sakata K, Kachi E, Hirata S, Ishihara T and Ishikawa K. Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study. American heart journal . 1998;135:937-44.
71. Danilowicz D, Rutkowski M, Myung D and Schively D. Echocardiography in duchenne muscular dystrophy.Muscle & nerve . 1980;3:298-303.
72. Brunklaus A, Parish E, Muntoni F, Scuplak S, Tucker SK, Fenton M, Hughes ML and Manzur AY. The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society . 2015;19:395-401.
73. Hor KN, Kissoon N, Mazur W, Gupta R, Ittenbach RF, Al-Khalidi HR, Cripe LH, Raman SV, Puchalski MD, Gottliebson WM and Benson DW. Regional circumferential strain is a biomarker for disease severity in duchenne muscular dystrophy heart disease: a cross-sectional study. Pediatr Cardiol . 2015;36:111-9.
74. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK, European Society of c and Soceity for Cardiovascular Magnetic R. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson . 2004;6:727-65.
75. Grothues F, Smith G, Moon J, Bellenger N, Collins P, Klein H and Pennell D. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol . 2002;90:29-34.
76. Ferreira VM, Piechnik SK, Robson MD, Neubauer S and Karamitsos TD. Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping.J Thorac Imaging . 2014;29:147-54.
77. Osman NF and Prince JL. Regenerating MR tagged images using harmonic phase (HARP) methods.IEEE transactions on bio-medical engineering . 2004;51:1428-33.
78. Earls JP, Ho VB, Foo TK, Castillo E and Flamm SD. Cardiac MRI: recent progress and continued challenges.J Magn Reson Imaging . 2002;16:111-27.
79. Tandon A, Villa CR, Hor KN, Jefferies JL, Gao Z, Towbin JA, Wong BL, Mazur W, Fleck RJ, Sticka JJ, Benson DW and Taylor MD. Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy. J Am Heart Assoc . 2015;4.
80. Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E and Gottliebson WM. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovasc Imaging . 2009;25:57-63.
81. D’Amario D, Amodeo A, Adorisio R, Tiziano FD, Leone AM, Perri G, Bruno P, Massetti M, Ferlini A, Pane M, Niccoli G, Porto I, D’Angelo GA, Borovac JA, Mercuri E and Crea F. A current approach to heart failure in Duchenne muscular dystrophy.Heart . 2017;103:1770-+.
82. Hagenbuch SC, Gottliebson WM, Wansapura J, Mazur W, Fleck R, Benson DW and Hor KN. Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy. Am J Cardiol . 2010;105:1451-5.
83. Robb JS and Robb RC. The normal heart - Anatomy and physiology of the structural units. Am Heart J . 1942;23:455-467.
84. Torrent-Guasp F, Buckberg GD, Clemente C, Cox JL, Coghlan HC and Gharib M. The structure and function of the helical heart and its buttress wrapping. I. The normal macroscopic structure of the heart. Semin Thorac Cardiovasc Surg . 2001;13:301-19.
85. Buckberg GD, Weisfeldt ML, Ballester M, Beyar R, Burkhoff D, Coghlan HC, Doyle M, Epstein ND, Gharib M, Ideker RE, Ingels NB, LeWinter MM, McCulloch AD, Pohost GM, Reinlib LJ, Sahn DJ, Sopko G, Spinale FG, Spotnitz HM, Torrent-Guasp F and Shapiro EP. Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease. Circulation . 2004;110:e333-6.
86. Helm P, Beg MF, Miller MI and Winslow RL. Measuring and mapping cardiac fiber and laminar architecture using diffusion tensor MR imaging. Ann N Y Acad Sci . 2005;1047:296-307.
87. Helm PA, Tseng HJ, Younes L, McVeigh ER and Winslow RL. Ex vivo 3D diffusion tensor imaging and quantification of cardiac laminar structure. Magn Reson Med . 2005;54:850-9.
88. Streeter DD, Jr., Spotnitz HM, Patel DP, Ross J, Jr. and Sonnenblick EH. Fiber orientation in the canine left ventricle during diastole and systole. Circ Res . 1969;24:339-47.
89. Wu EX, Wu Y, Tang H, Wang J, Yang J, Ng MC, Yang ES, Chan CW, Zhu S, Lau CP and Tse HF. Study of myocardial fiber pathway using magnetic resonance diffusion tensor imaging. Magn Reson Imaging . 2007;25:1048-57.
90. Hor KN, Kissoon N, Mazur W, Gupta R, Ittenbach RF, Al-Khalidi HR, Cripe LH, Raman SV, Puchalski MD, Gottliebson WM and Benson DW. Regional circumferential strain is a biomarker for disease severity in duchenne muscular dystrophy heart disease: a cross-sectional study. Pediatr Cardiol . 2015;36:111-9.
91. Castillo E, Osman NF, Rosen BD, El-Shehaby I, Pan L, Jerosch-Herold M, Lai S, Bluemke DA and Lima JA. Quantitative assessment of regional myocardial function with MR-tagging in a multi-center study: interobserver and intraobserver agreement of fast strain analysis with Harmonic Phase (HARP) MRI. J Cardiovasc Magn Reson . 2005;7:783-91.
92. Almeida AL, Teixido-Tura G, Choi EY, Opdahl A, Fernandes VR, Wu CO, Bluemke DA and Lima JA. Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis. Arquivos brasileiros de cardiologia . 2014;102:327-35.
93. Delgado V, Tops LF, van Bommel RJ, van der Kley F, Marsan NA, Klautz RJ, Versteegh MI, Holman ER, Schalij MJ and Bax JJ. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. Eur Heart J . 2009;30:3037-47.
94. Helm RH and Lardo AC. Cardiac magnetic resonance assessment of mechanical dyssynchrony. Current opinion in cardiology . 2008;23:440-6.
95. Gotte MJ, Germans T, Russel IK, Zwanenburg JJ, Marcus JT, van Rossum AC and van Veldhuisen DJ. Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function. J Am Coll Cardiol . 2006;48:2002-11.
96. Moore CC, Lugo-Olivieri CH, McVeigh ER and Zerhouni EA. Three-dimensional systolic strain patterns in the normal human left ventricle: characterization with tagged MR imaging. Radiology . 2000;214:453-66.
97. Smiseth OA, Torp H, Opdahl A, Haugaa KH and Urheim S. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J . 2016;37:1196-207.
98. Kuijer JP, Marcus JT, Gotte MJ, van Rossum AC and Heethaar RM. Three-dimensional myocardial strain analysis based on short- and long-axis magnetic resonance tagged images using a 1D displacement field. Magnetic resonance imaging . 2000;18:553-64.
99. Torrent-Guasp F, Kocica MJ, Corno AF, Komeda M, Carreras-Costa F, Flotats A, Cosin-Aguillar J and Wen H. Towards new understanding of the heart structure and function. Eur J Cardiothorac Surg . 2005;27:191-201.
100. Streeter DD, Jr. and Hanna WT. Engineering mechanics for successive states in canine left ventricular myocardium. I. Cavity and wall geometry. Circ Res . 1973;33:639-55.
101. Sengupta PP, Korinek J, Belohlavek M, Narula J, Vannan MA, Jahangir A and Khandheria BK. Left ventricular structure and function: basic science for cardiac imaging.J Am Coll Cardiol . 2006;48:1988-2001.
102. Osman NF, Kerwin WS, McVeigh ER and Prince JL. Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magnetic resonance in medicine . 1999;42:1048-60.
103. Osman NF and Prince JL. Visualizing myocardial function using HARP MRI. Physics in medicine and biology . 2000;45:1665-82.
104. Valeti VU, Chun W, Potter DD, Araoz PA, McGee KP, Glockner JF and Christian TF. Myocardial tagging and strain analysis at 3 Tesla: comparison with 1.5 Tesla imaging.Journal of magnetic resonance imaging : JMRI . 2006;23:477-80.
105. Garot J, Lima JA, Gerber BL, Sampath S, Wu KC, Bluemke DA, Prince JL and Osman NF. Spatially resolved imaging of myocardial function with strain-encoded MR: comparison with delayed contrast-enhanced MR imaging after myocardial infarction.Radiology . 2004;233:596-602.
106. Bogaert J, Bosmans H, Maes A, Suetens P, Marchal G and Rademakers FE. Remote myocardial dysfunction after acute anterior myocardial infarction: impact of left ventricular shape on regional function: a magnetic resonance myocardial tagging study. J Am Coll Cardiol . 2000;35:1525-34.
107. Hor KN, Hagenbuch SC, Fleck RJ, Wansapura JP, Mazur W, Benson DW and Gottliebson WM. Serial Evaluation of Circumferential Strain for Monitoring of Progressive Cardiac Dysfunction in Duchenne Muscular Dystrophy Patients. Journal of the American College of Cardiology . 2009;53:A283-A283.
108. Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson DW and Gottliebson WM. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.J Am Coll Cardiol . 2009;53:1204-10.
109. Wesbey G, Higgins CB, Lanzer P, Botvinick E and Lipton MJ. Imaging and characterization of acute myocardial infarction in vivo by gated nuclear magnetic resonance.Circulation . 1984;69:125-30.
110. Wesbey GE, Higgins CB, McNamara MT, Engelstad BL, Lipton MJ, Sievers R, Ehman RL, Lovin J and Brasch RC. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology . 1984;153:165-9.
111. Tscholakoff D, Higgins CB, Sechtem U and McNamara MT. Occlusive and reperfused myocardial infarcts: effect of Gd-DTPA on ECG-gated MR imaging. Radiology . 1986;160:515-9.
112. McNamara MT, Higgins CB, Ehman RL, Revel D, Sievers R and Brasch RC. Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA.Radiology . 1984;153:157-63.
113. McNamara MT, Tscholakoff D, Revel D, Soulen R, Schechtmann N, Botvinick E and Higgins CB. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology . 1986;158:765-9.
114. Saeed M, Wendland MF, Takehara Y and Higgins CB. Reversible and irreversible injury in the reperfused myocardium: differentiation with contrast material-enhanced MR imaging.Radiology . 1990;175:633-7.
115. Eichstaedt HW, Felix R, Dougherty FC, Langer M, Rutsch W and Schmutzler H. Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA. Clinical cardiology . 1986;9:527-35.
116. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A and Judd RM. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation . 2008;117:629-37.
117. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO and Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med . 2000;343:1445-53.
118. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP and Judd RM. An improved MR imaging technique for the visualization of myocardial infarction.Radiology . 2001;218:215-23.
119. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M and Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function.Circulation . 2001;104:1101-7.
120. Fieno DS, Hillenbrand HB, Rehwald WG, Harris KR, Decker RS, Parker MA, Klocke FJ, Kim RJ and Judd RM. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol . 2004;43:2124-31.
121. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS and Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation . 2000;102:1678-83.
122. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E and Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation . 1995;92:1117-25.
123. Ramani K, Judd RM, Holly TA, Parrish TB, Rigolin VH, Parker MA, Callahan C, Fitzgerald SW, Bonow RO and Klocke FJ. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation . 1998;98:2687-94.
124. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P and Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol . 2004;43:2253-9.
125. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM, Gheorghiade M and Kim RJ. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation . 2003;108:1945-53.
126. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ and Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.Circulation . 2003;108:54-9.
127. Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, Kalil-Filho R, Mady C, Meneghetti JC, Lima JA and Ramires JA. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol . 2005;46:1553-8.
128. Ryan TD, Taylor MD, Mazur W, Cripe LH, Pratt J, King EC, Lao K, Grenier MA, Jefferies JL, Benson DW and Hor KN. Abnormal circumferential strain is present in young Duchenne muscular dystrophy patients. Pediatr Cardiol . 2013;34:1159-65.
129. Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, Tran T, Smart S, McCarthy B, Taylor MD, Jefferies JL, Rafael-Fortney JA, Lowe J, Roble SL and Cripe LH. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol . 2015;14:153-61.
130. Raman SV, Hor KN, Mazur W, He X, Kissel JT, Smart S, McCarthy B, Roble SL and Cripe LH. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial. Orphanet J Rare Dis . 2017;12:39.
131. Raman SV, Hor KN, Mazur W, Cardona A, He X, Halnon N, Markham L, Soslow JH, Puchalski MD, Auerbach SR, Truong U, Smart S, McCarthy B, Saeed IM, Statland JM, Kissel JT and Cripe LH. Stabilization of Early Duchenne Cardiomyopathy With Aldosterone Inhibition: Results of the Multicenter AIDMD Trial. J Am Heart Assoc . 2019;8:e013501.
132. Kellman P, Bandettini WP, Mancini C, Hammer-Hansen S, Hansen MS and Arai AE. Characterization of myocardial T1-mapping bias caused by intramyocardial fat in inversion recovery and saturation recovery techniques. J Cardiovasc Magn Reson . 2015;17:33.
133. Kellman P and Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson . 2014;16:2.
134. Lundin M, Sorensson P, Vishnevskaya L, Maret E, Kellman P, Sigfridsson A and Ugander M. Detection of myocarditis using T1 and ECV mapping is not improved by early compared to late post-contrast imaging. Clin Physiol Funct Imaging . 2019;39:384-392.
135. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU and Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med . 2004;52:141-6.
136. Messroghli DR, Greiser A, Frohlich M, Dietz R and Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging . 2007;26:1081-6.
137. Fontana M, White SK, Banypersad SM, Sado DM, Maestrini V, Flett AS, Piechnik SK, Neubauer S, Roberts N and Moon JC. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson . 2012;14:88.
138. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C and Moon JC. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation . 2010;122:138-44.
139. Soslow JH, Damon BM, Saville BR, Lu Z, Burnette WB, Lawson MA, Parra DA, Sawyer DB and Markham LW. Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging. Pediatr Cardiol . 2015;36:49-56.
140. Soslow JH, Damon SM, Crum K, Lawson MA, Slaughter JC, Xu M, Arai AE, Sawyer DB, Parra DA, Damon BM and Markham LW. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy. J Cardiovasc Magn Reson . 2016;18:5.
141. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K and Guidelines ESCCfP. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur Heart J . 2008;29:2388-442.
142. Fonseca C. Diagnosis of heart failure in primary care. Heart Fail Rev . 2006;11:95-107.
143. Davie AP, Francis CM, Caruana L, Sutherland GR and McMurray JJ. Assessing diagnosis in heart failure: which features are any use? QJM . 1997;90:335-9.
144. Oudejans I, Mosterd A, Bloemen JA, Valk MJ, van Velzen E, Wielders JP, Zuithoff NP, Rutten FH and Hoes AW. Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail . 2011;13:518-27.
145. Chen J, Normand SL, Wang Y and Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA . 2011;306:1669-78.
146. Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, Mant D, McManus RJ, Holder R, Deeks J, Fletcher K, Qume M, Sohanpal S, Sanders S and Hobbs FD. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess . 2009;13:1-207, iii.
147. Rutten FH, Moons KG, Cramer MJ, Grobbee DE, Zuithoff NP, Lammers JW and Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ . 2005;331:1379.
148. Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AHB, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA and Maisel AS. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure: Results from the Breathing Not Properly Multinational Study. Am Heart J . 2006;151:999-1005.
149. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG and McMurray JJ. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology.Eur J Heart Fail . 2009;11:130-9.
150. Hawkins NM, Virani S and Ceconi C. Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J . 2013;34:2795-803.
151. Shih JA, Folch A and Wong BL. Duchenne Muscular Dystrophy: the Heart of the Matter. Curr Heart Fail Rep . 2020;17:57-66.
152. Hor KN, Mazur W, Taylor MD, Al-Khalidi HR, Cripe LH, Jefferies JL, Raman SV, Chung ES, Kinnett KJ, Williams K, Gottliebson WM and Benson DW. Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance. J Cardiovasc Magn R . 2011;13.
153. Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, Tran T, Smart S, McCarthy B, Taylor MD, Jefferies JL, Rafael-Fortney JA, Lowe J, Roble SL and Cripe LH. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol . 2015;14:153-161.
154. Soslow JH, Damon BM, Saville BR, Lu Z, Burnette WB, Lawson MA, Parra DA, Sawyer DB and Markham LW. Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging. Pediatr Cardiol . 2015;36:49-56.
155. Soslow JH, Damon SM, Crum K, Lawson MA, Slaughter JC, Xu M, Arai AE, Sawyer DB, Parra DA, Damon BM and Markham LW. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance . 2016;18:5.
156. Wittlieb-Weber CA, Knecht KR, Villa CR, Cunningham C, Conway J, Bock MJ, Gambetta KE, Lal AK, Schumacher KR, Law SP, Deshpande SR, West SC, Friedland-Little JM, Lytrivi ID, McCulloch MA, Butts RJ, Weber DR and Johnson JN. Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy. Pediatr Cardiol . 2020;41:764-771.